XKRX
038290
Market cap98mUSD
Oct 08, Last price
12,180.00KRW
1D
-2.33%
1Q
0.83%
Jan 2017
-62.98%
IPO
-44.80%
Name
Macrogen Inc
Chart & performance
P/E
65.05
P/S
0.68
EPS
187.25
Div yield, %
2.46%
Shrs. gr., 5y
1.60%
Rev. gr., 5y
11.64%
Revenues
195.27b
+43.82%
Net income
2.03b
P
CFO
21.50b
+201.87%
Dividend
Dec 29, 2025300 KRW/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Macrogen, Inc. specializes in offering a wide array of services within genetic research and biotechnology. Their core offerings span various solutions, including whole-genome, clinical, and personalized DNA sequencing, as well as oligonucleotide synthesis, microarray analysis, and the creation of genetically engineered mice. This company was established on June 5, 1997, and its corporate headquarters are situated in Seoul, South Korea.
Key people
Ji Yeong Moon
Chief Financial Officer, Director · since 2013
Internal Auditor
Seok Hwa Kim
Director · since 2006
Chang Hun Kim
Chief Executive Officer, Director · since 2022
Chairman of the Board · since 2005
Valuation
Title KRW in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
| Income | |||||||
Revenues | |||||||
Cost of revenue | |||||||
Unusual Expense (Income) | |||||||
NOPBT | |||||||
NOPBT Margin | |||||||
Operating Taxes | |||||||
Tax Rate | |||||||
NOPAT | |||||||
Net income | |||||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | |||||||
BB yield | |||||||
| Debt | |||||||
Debt current | |||||||
Long-term debt | |||||||
Deferred revenue | |||||||
Other long-term liabilities | |||||||
Net debt | |||||||
| Cash flow | |||||||
Cash from operating activities | |||||||
CAPEX | |||||||
Cash from investing activities | |||||||
Cash from financing activities | |||||||
FCF | |||||||
| Balance | |||||||
Cash | |||||||
Long term investments | |||||||
Excess cash | |||||||
Stockholders' equity | |||||||
Invested Capital | |||||||
ROIC | |||||||
ROCE | |||||||
| EV | |||||||
Common stock shares outstanding | |||||||
Price | |||||||
Market cap | |||||||
EV | |||||||
EBITDA | |||||||
EV/EBITDA | |||||||
Interest | |||||||
Interest/NOPBT | |||||||